Efficacy of APOQUEL® for the Control of Otitis Externa Secondary to Allergic Skin Disease in Client-Owned Dogs
Journal Title: International Journal of Veterinary Health Science & Research (IJVHSR) - Year 2017, Vol 5, Issue 7
Abstract
Background: This single-arm, unmasked, single-site study was conducted to evaluate the efficacy of oclacitinib (APOQUEL®) administered twice daily for 14 days with a topical anti-infective, when indicated, for the control of otitis externa secondary to allergic skin disease in dogs. Thirteen (13) client-owned dogs were enrolled; three (3) dogs were withdrawn for owner non-compliance. Dogs were required to be ≥1 year old, weigh 3.0-80.0 kg, have uncomplicated otitis externa that the Investigator attributed to allergic skin disease, have an Otitis Index Score of ≥6 and been withdrawn from any systemic or topical treatments with antipruritic, anti-inflammatory or anti-infective properties that could interfere with assessments. Cytology samples were collected from each ear. Ears with otitis externa were cleaned at enrollment. Oclacitinib was administered orally twice daily; in dogs with evidence of infection, enrofloxacin/silver sulfadiazine (Baytril® Otic) was administered topically twice daily in affected ears. Owner assessments were performed daily and Investigator assessments were performed on Days 7 and 14. Results: Seven (7) female and three (3) male dogs completed the study. Ages ranged from 3.0-12.0 years and body weight ranged from 3.6-47.0 kg. Administration of oclacitinib and enrofloxacin/silver sulfadiazine twice daily for 14 days resulted in mean Investigator otitis scores improving from 19.7 on Day 0 to 3.4 by Day 14, for a mean reduction of 81.7%. Mean owner assessment improved by 94.7% (left ear) and 80.6% (right ear) during the 14-day study. Cytologic examination of the ears showed bacteria in seven left ears and seven right ears at enrollment compared to only one left ear and no right ears on Day 14. One dog had no bacteria or yeast on Day 0 compared to nine dogs with no bacteria on Day 14. Yeast was present in two left and two right ears at enrollment and in only one right ear on Day 14. Conclusions: The results of this single-arm, single-site, unmasked study suggest that oral administration of oclacitinib with a topical anti-infective applied to affected ears twice daily for 14 days is effective for the management of otitis externa secondary to allergic skin disease in dogs.
Authors and Affiliations
Louis N. Gotthelf
Keywords
Related Articles
- EP ID EP327464
- DOI 10.19070/2332-2748-1700041
- Views 87
- Downloads 0
Cereals Bond Trounces Subacute Rumen Acidosis
Cereals Bond Trounces Subacute Rumen Acidosis
Allometric and Phylogenic Comparisons of Circulating Leukocyte Concentrations between and within Birds and Mammals
The blood concentrations of leukocytes and the major classes of leukocytes were compared across over 200 species of birds and over 300 species of mammals based on phylogenic relations, body weight and diet. The concentra...
Surgical Management of Bumble foot in a cock
Bumble foot or plantar pododermatitis, is an inflammatory and typically infected lesion of the plantar aspect of the foot, affecting either the ball of the foot or one or more toes. A case of bumble foot in a 6 year old...
Mechanistic Toxicity Assessment of Hexahydroisohumulone in Canine Hepatocytes, Renal Proximal Tubules, Bone Marrow-Derived Mesenchymal Stem Cells, and Enterocyte-like Cells
In vitro test methods are used primarily for rapid screening of chemicals based on mechanistic understanding of toxicity to predict hazards and potential risks. We investigated organ-specific oxidative stress and the mol...
An Abattoir Based Study on Brucellosis, Bovine Tuberculosis and Paratuberculosis in Buffaloes and Cattle at Faisalabad, Pakistan
A study was carried out to investigate the prevalence of these diseases at Faisalabad abattoirs in buffaloes and cattle. For this purpose, 400 consecutive animals, including 200 buffaloes and 200 cattle were included in...